RxDoctor Payments Data

Irene Malaty, MD

Neurology · Gainesville, FLNPI 1134295694

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $30,600 of the $32,978 with a category attached, or 92.8%. AbbVie accounts for 91.3% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $20,901, more than ten times the $1,805 reported in 2021.

$32,978in general payments, 2019–2025

Across 30 payments — averaging $1099.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$30K
  • Acadia Pharmaceuticals Inc$2K
  • Sage Therapeutics, LLC$1K
  • CSL Behring$20
$249,360in research payments, 2019–2025

Across 40 payments — averaging $6234.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$171K
  • Sage Therapeutics, LLC$78K

What the payments were for

  • Consulting fees$30,60093%
  • Travel & lodging$1,8516%
  • Food & beverage$5022%
  • Education$250%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie21$30,101
Acadia Pharmaceuticals Inc4$1,805
Sage Therapeutics, LLC4$1,052
CSL Behring1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,978 in reported general payments places this provider in the 85th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida →

Medicare billing

Part B allowed, 2024
$760,290
Medicare patients
350
Services billed
98,851

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine22$157,805
RytaryCarbidopa/Levodopa16$19,022
Carbidopa11$7,409
Carbidopa-LevodopaCarbidopa/Levodopa114$7,111
Carbidopa-Levodopa ErCarbidopa/Levodopa39$1,773
Clozapine70$1,766
Selegiline Hcl13$1,215
Primidone19$965
AmantadineAmantadine Hcl22$477
Clonazepam35$261
Escitalopram Oxalate18$249
Topiramate27$248
Sertraline Hcl23$150
Gabapentin18$121
Citalopram HbrCitalopram Hydrobromide13$64

Paid to pharmacies, not to this prescriber.

Other neurology in Gainesville

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →